Physician profile
Byron T Jeffcoat
NPI 1750339172
$1,562.43
in general payments reported to CMS, 2019-2025
21 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $223 · 2021: $133 · 2022: $106 · 2023: $341 · 2024: $205 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $395.67 | 2019-2024 | Collagenase Santyl, Regranex |
| Paratek Pharmaceuticals, INC. | $286.88 | 2023-2025 | Nuzyra |
| Pacira Therapeutics, INC. | $174.53 | 2019-2021 | |
| Grifols USA, LLC | $116.06 | 2025 | Prolastin-C Liquid |
| Amgen INC. | $99.20 | 2022-2025 | Evenity, Prolia |
| Convatec INC. | $61.06 | 2022-2023 | |
| Hydrofera LLC | $49.97 | 2023-2024 | Hydrofera Blue |
| Vertex Pharmaceuticals Incorporated | $48.69 | 2025 | |
| Bioventus LLC | $43.28 | 2021-2023 | Durolane |
| Kerecis Limited | $42.90 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $37.82 | 2021 | |
| Medela LLC | $33.52 | 2020 | |
| Medline Industries Lp | $31.08 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $23.55 | 2025 | Zilretta, Exparel |
| Sandoz INC. | $22.47 | 2025 | Jubbonti |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $20.91 | 2023 | |
| Integra Lifesciences Corporation | $17.79 | 2019 | |
| Baudax Bio INC. | $15.63 | 2020 | |
| Sanara Medtech INC. | $13.88 | 2023 | Celleraterx |
| Allergan, INC. | $13.84 | 2019 | |
| Zimmer Biomet Holdings, INC. | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Jeffcoat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.